ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00242840
Recruitment Status : Completed
First Posted : October 21, 2005
Last Update Posted : May 30, 2017
Sponsor:
Information provided by (Responsible Party):
ViiV Healthcare

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2006
  Actual Study Completion Date : January 2006